Cogent Biosciences Inc (COGT)
US$ 10.211.59%
Price Chart
Key Statistics
Market Cap
$ 604.58M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.24M
52W High
$ 12.61
52W Low
$ 3.72
Dividend Yield
0.00%
Beta
0.22
Technicals
50-Day MA
5.5073
200-Day MA
8.4691
52 Week High
12.61
52 Week Low
3.72
About COGT
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases.
Employees
205
Headquarters
Waltham, MA
CEO
Mr. Andrew R. Robbins M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg